Developed at Monash University in Australia, AOD9604 was designed to isolate the lipolytic activity attributed to the C-terminal region of hGH while excluding the growth-promoting and diabetogenic effects associated with the full-length hormone
Before treatment, clients often experience low energy, difficulty losing weight, or sluggish metabolism
An unusual warmth, pain, or redness in the arm or leg is a serious potential side effect
Advanced injectable protocol Goal: Maximum efficacy, willing to inject, committed to comprehensive protocol
AOD-9604 (10mg vials) At-Home Blood Test Research Supplies Disclosure: supply links may earn PDP a commission at no cost to you
As the body's primary G-actin sequestering peptide, it maintains pools of monomeric actin available for rapid cytoskeletal reorganization, accelerating cell migration from distant sites to the wound